We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Brain Cancer

Journal Scan / Research · July 16, 2020

Targeting Mutant PPM1D Sensitizes DIPG Cells to the PARP Inhibitor Olaparib

Molecular cancer research : MCR

 

Additional Info

Molecular cancer research : MCR
Targeting Mutant PPM1D Sensitizes Diffuse Intrinsic Pontine Glioma Cells to the PARP Inhibitor Olaparib
Mol. Cancer Res. 2020 Jul 01;18(7)968-980, Z Wang, C Xu, BH Diplas, CJ Moure, CJ Chen, LH Chen, C Du, H Zhu, PK Greer, L Zhang, Y He, MS Waitkus, H Yan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading